Welcome to LookChem.com Sign In|Join Free
  • or
1-[2-(2-chloro-5-nitrophenoxy)ethyl]-1H-pyrazole is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1453211-72-7

Post Buying Request

1453211-72-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1453211-72-7 Usage

Chemical structure

A pyrazole derivative with a chloro and nitro group attached to a phenoxyethyl group

Usage

Commonly used as a building block in organic synthesis and pharmaceutical research

Potential applications

Agricultural chemical, insecticidal and fungicidal properties

Research areas

Medicinal chemistry, anti-cancer agent, treatment for neurodegenerative diseases

Ongoing research

Exploring various potential uses in different fields

Check Digit Verification of cas no

The CAS Registry Mumber 1453211-72-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,5,3,2,1 and 1 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1453211-72:
(9*1)+(8*4)+(7*5)+(6*3)+(5*2)+(4*1)+(3*1)+(2*7)+(1*2)=127
127 % 10 = 7
So 1453211-72-7 is a valid CAS Registry Number.

1453211-72-7Relevant academic research and scientific papers

NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND

-

Paragraph 0293, (2014/05/25)

Provided is a compound useful as a prophylactic and/or therapeutic agent for bladder cancer. As a result of studies on compounds having FGFR inhibitory action, the present inventors have found that the nitrogen-containing aromatic heterocyclic compounds of the present invention have inhibitory action on FGFR1, FGFR2, and/or FGFR3, particularly, mutant FGFR3, and thus, the present invention has been accomplished. The nitrogen-containing aromatic heterocyclic compound of the present invention can be used as a therapeutic agent for various cancers related to FGFR1, FGFR2, and/or FGFR3, such as lung cancer and hormone therapy-resistant breast cancer, stomach cancer, triple negative breast cancer, endometrial cancer, bladder cancer, and glioblastoma, particularly as a prophylactic and/or therapeutic agent for mutant FGFR3-positive bladder cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1453211-72-7